ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,400Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 670

$559K Total Retail Price of All Prescriptions

Rank: 158 out of 670

285 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 285 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

49% of this provider’s 285 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 2,030 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,001 149 S3 1 1
METFORMIN HCL 328 73 2 8
NEXIUM 313 22 3 14
LEVOTHYROXINE SODIUM 298 53 4 2
SIMVASTATIN 233 48 5 4
FUROSEMIDE 225 76 6 6
PROAIR HFA 225 22 6 28
HYDROCHLOROTHIAZIDE 224 39 8 10
IBUPROFEN 212 32 9 50
OMEPRAZOLE 206 38 10 5
ZOLPIDEM TARTRATE 204 42 11 23
ATORVASTATIN CALCIUM 187 32 12 15
OXYCODONE-ACETAMINOPHEN 152 0 S2 13 77
LISINOPRIL 148 59 14 3
GABAPENTIN 144 18 15 11
NIASPAN 142 47 16 116
CYCLOBENZAPRINE HCL 141 0 R 17 61
SINGULAIR 137 14 18 56
ATENOLOL 130 30 19 17
AMPHETAMINE SALT COMBO 129 0 S2 20 246
METOPROLOL TARTRATE 128 47 21 9
LYRICA 118 0 22 65
CLOPIDOGREL 118 47 22 24
ENDOCET 113 0 S2 24 146
METOPROLOL SUCCINATE 109 27 25 12
RANITIDINE HCL 104 29 26 25
SPIRIVA 98 13 27 51
CARISOPRODOL 97 0 R 28 161
AZITHROMYCIN 96 12 29 35
ADVAIR DISKUS 83 17 30 42
BENICAR HCT 80 12 31 190
COMBIVENT 80 34 31 167
ROPINIROLE HCL 78 0 33 75
CYMBALTA 76 11 34 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 18 35 27
TRAMADOL HCL 73 15 36 21
ALENDRONATE SODIUM 73 20 36 43
CRESTOR 71 0 38 18
MONTELUKAST SODIUM 70 11 39 96
TOPIRAMATE 69 11 40 162
ENALAPRIL MALEATE 69 0 40 49
DEXTROAMPHETAMINE-AMPHETAMINE 67 0 S2 42 337
DEXILANT 65 0 43 70
PAROXETINE HCL 64 0 44 52
PROPRANOLOL HCL 61 24 45 130
LIPITOR 60 0 46 156
VENTOLIN HFA 58 22 47 163
OXYCODONE HCL-ACETAMINOPHEN 58 11 S2 47 71
PLAVIX 57 20 49 34
TRICOR 56 11 50 83
PANTOPRAZOLE SODIUM 54 36 51 41
VENLAFAXINE HCL ER 54 0 51 97
WARFARIN SODIUM 54 23 51 13
METOCLOPRAMIDE HCL 53 15 54 117
SERTRALINE HCL 52 23 55 22
LOVASTATIN 51 0 56 44
ISOSORBIDE MONONITRATE ER 50 29 57 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.